Three common proviral integration sites, Fim-1, Fim-2/c-fms, and Fim-3, have been described in mouse myeloid leukemias induced by the Friend murine leukemia virus. The nature and function of Fim-1 and Fim-3 are still unknown since no transcript from these loci has been detected so far. To identify these two loci, we undertook their chromosomal localization using restriction fragment length polymorphism detected between C57BL/6 mice and the wild-derived inbred strain of Mus spretus. Using interspecific backcross analysis, we mapped Fim-1 to mouse chromosome 13 and Fim-3 to mouse chromosome 3. Interestingly, Fim-3 is tightly linked to Evi-1, another common integration site of ecotropic virus involved in another model of mouse myeloid leukemogenesis. Fim-2 spans the 5' end of the c-fms gene, which encodes for the macrophage-colonystimulating factor receptor. We located the c-fms gene on the D band of chromosome 18 by in situ hybridization.
Nonacute leukemia viruses induce cellular transformation mainly by an insertional mutagenesis mechanism. Thus, proto-oncogenes such as c-erbB (7), c-myc (5, 16, 29) , and c-myb (28, 37) are frequently activated by retroviral integration either by downstream promotion or by an enhancer effect of the proviral long terminal repeat. In addition, numerous putative proto-oncogenes are activated by retroviral integration. They were recently discovered by the "transposon tagging" strategy: the newly acquired proviruses in tumor cells are used as probes to identify cellular loci implicated in the transformation process. By cloning virus/host cellular junction fragments, unique cellular sequences are identified and used to screen other tumors. By this approach, common proviral integration sites were described in different species and in different virus-induced tumor systems such as Int-i (31), Int-2 (33), Int-3 (8) , and Int41 (9) for the mouse mammary tumor virus-induced mammary carcinomas; Spi-i for spleen focus-forming virusinduced erythroleukemias (25) ; and Pim-1 (6), Fis-i (39), Gin-i (47), Mlvi-i (44), Mlvi-2 and Mlvi-3 (45), Mis-ilPvt-i (12, 21), Dsi-i (46), Evi-i (27) , and Evi-2 (4) for murine leukemia virus (MuLV)-induced mouse or rat leukemias.
We have previously described three common proviral integration sites of the Friend MuLV (F-MuLV) in mouse myeloblastic leukemias (2, 41) . These three regions, Fim-1, Fim-2, and Fim-3, are involved in 3, 26, and 26%, respectively, of the leukemias tested. Fim-2 spans the 5' end of the c-fms proto-oncogene, and proviral insertion in this region leads to the overexpression of a normal-sized c-fms mRNA (10) . Since c-fms codes for the macrophage-colony-stimulating factor (M-CSF) receptor, we can infer that overexpression of this receptor may play a role in myeloblastic leukemogenesis. Fim-1 and Fim-3 are well conserved * Corresponding author. throughout evolution, but their nature and function are still under investigation. We undertook their chromosomal mapping to verify that these two regions were different from proto-oncogenes, growth factor genes, or growth factor receptor genes and from previously described common integration sites. This was done using the restriction fragment length polymorphisms (RFLPs) detected in interspecific mouse backcrosses. Mus spretus is very useful for genetic analysis since it is evolutionary divergent from the classical inbred laboratory strains and polymorphism is detected at many loci between the two species of mice (14, 35) . In addition, the chromosomal location of the mouse c-fms gene was determined by the in situ hybridization technique.
We found that Fim-1 maps to chromosome 13, Fim-3 to chromosome 3, and Fim-21c-fms to chromosome 18. The genetic linkage between Fim-3 and Evi-1, a common site of ecotropic viral integration in AKXD murine myeloid tumors (27) , is also reported. Male backcross animals used in this study were also characterized by F. Bonhomme and colleagues (Centre National de la Recherche Scientifique UA327, Montpellier, France) for the segregation of 15 biochemical markers already localized on the mouse genetic map.
DNA isolation and Southern blot analysis. High-molecularweight DNA was extracted from frozen spleen as previously described (48) . DNAs (5 ,ug) blot transfer, and hybridization were performed as previously described (42) . Chromosome spread preparation. In situ hybridization experiments were carried out using metaphase spreads from a male mouse of the WMP/Pas inbred strain, in which all autosomes except 19 are involved in Robertsonian translocations. Concanavalin A-stimulated lymphocytes were cultured at 37°C for 72 h, with 5-bromodeoxyuridine added for the final 6 h of culture (60 ,ug/ml of medium) to ensure a good-quality chromosomal R-banding.
Probe preparation and in situ hybridization. The Fim-2 17(1)-BX11 probe was tritium labeled by nick-translation to a specific activity of 8.8 x 107 dpm/,ug. The radiolabeled probe was hybridized to metaphase spreads at a final concentration of 100 ng/ml of hybridization solution as previously described (23) .
Autoradiography, staining, and banding. After coating with nuclear track emulsion (Kodak NTB2), the slides were exposed for 8 days at 4°C and then developed. To avoid any slipping of silver grains during the banding procedure, chromosome spreads were first stained with buffered Giemsa solution and metaphases were photographed. R-banding was then performed by the fluorochrome-photolysis-Giemsa method, and metaphases were rephotographed before analysis. Probes Chromosomal localization of Fim-) and Fim-3. Studies of interspecific backcrosses indicated that Fim-1 was located on chromosome 13. The chromosome 13 markers used were a VT-y5 probe isolated from the variable region of the -y chain of the T-cell receptor gene (40); PL5, an anonymous probe (22) ; 4/12, a probe that corresponds to a flanking region of an integrated hepatitis B virus into a transgenic strain of mouse (15) ; and a CTLA-3 probe cloned from the serine esterase gene (3) ( Table 2) . No evidence of linkage was observed between CTLA-3 and any other chromosome 13 markers. This result is in agreement with in situ hybridization experiments which have located CTLA-3 on the distal part of chromosome 13 (M.-G. Mattei, unpublished results).
In contrast, genetic linkage was observed between all other markers. Only one recombinant was detected between PL5 and 4/12, indicating that these two loci are separated by 2.0 centimorgans (cM) (95% confidence limit). The genetic distance between Fim-J and PL5 (14.6 ± 4.0 cM) and Fim-J and VTy5 (14.5 + 5.0 cM) on one hand, and PL5 and VT-y5 (25.0 ± 6.2 cM) on the other hand, indicates that Fim-1 is localized approximately at the same distance between these two loci. The -y chain of the murine T-cell receptor is known to map near the beige coat color locus on the proximal part of chromosome 13 (19, 32) . This would suggest a gene order of centromere-y chain-Fim-l-PL5-4/12-CTLA-3 (see Table   2 ).
No cosegregation of Fim-J and Fim-3 was observed. Instead, Fim-3 was linked to chromosome 3 markers. The segregation of Fim-3 with chromosome 3 markers (Adh-1, Amy, Hao-2, Pk-1) is presented and analyzed in Table 3 . These results indicate that Fim-3 is located at 37.3 ± 5.6 cM from Adh-1, 33.8 ± 5.5 cM from Amy, 29.3 + 5.3 cM from Hao-2, and 32.6 ± 6.7 cM from Pk-1.
A common site of integration of ecotropic MuLV in AKXD myeloid tumors (Evi-J) has been recently described (27) and found to be localized on the proximal part of mouse chromosome 3 (26) . To determine the genetic linkage between Evi-1 and Fim-3, Evi-J segregation was studied by Southern blot analysis using a TaqI RFLP which allows differentiation between C57BL/6 and M. spretus DNAs (26) . Among 90 backcross mice, no recombinant was detected between Fim-3 and Evi-J, indicating that these two loci are tightly linked (<2 cM at the 95% limit). a Numbers refer to the number of recombinants per total number of animals analyzed. Parentheses indicate percent recombination + standard deviation. These data suggest a gene order of centromere-Fim-3/Evi-I-PK-1-Hao-2-Amy-Adh-1.
Localization of Fim-2/c-fms on chromosome 18 by in situ hybridization. No clear genetic linkage between Fim-21c-fms and any chromosome marker could be found by using interspecific backcross analysis. In particular, no cosegregation was observed with Fim-1, Fim-3, and 48 chromosome markers. The human c-FMS gene has been localized on human chromosome 5 at band 5q34 (13, 36) and is linked to the IL3 and GM-CSF genes localized at band 5q23-31 (20, 34) . Murine IL3 and GM-CSF genes have been found to be linked on mouse chromosome 11 by both interspecific backcross analysis and pulsed-field gel electrophoresis (1). To determine whether c-fms is also on mouse chromosome 11, we used BamHI RFLPs for the GM-CSF locus. Two other chromosome 11 markers were used, the biochemical Esterase-3 marker and the MLC1A probe, corresponding to the cardiac myosin light-chain gene (Myla) (35) . Results of segregation were inconsistent with chromosome 11 linkage (data not shown). Therefore, Fim-21c-fms location was studied by in situ hybridization on mouse metaphase preparations. In the 100 metaphase cells examined, 172 silver grains were associated with chromosomes and 35 of these (20%) were located on chromosome 18. The distribution of grains on this chromosome was not random: 85% of them mapped to the (C-D-E) region of chromosome 18, with a maximum in the D band (Fig. 1) . These data allowed us to map the Fim-21 c-fms gene to the D band of chromosome 18. This result is consistent with the percentage of recombination obtained with the MBP chromosome 18 marker (33.3 + 6.0 cM) used in interspecific backcross analysis, since the MBP gene is located at the distal part of mouse chromosome 18 (38) .
DISCUSSION
We have cloned three common integration sites of FMuLV in murine myeloblastic leukemias (2, 41) . One of these sites, Fim-2, spans the 5' end of the murine c-fms gene (10) . The nature of the genes activated by insertion in the Fim-1 and Fim-3 regions is still unknown since no mRNA corresponding to these integration regions has so far been detected. We knew from mRNA analysis that integration of proviruses in the Fim-1 or in the Fim-3 region did not result in high expression of c-fms mRNA. Moreover, no correlation was found with the expression either of other oncogenes such as c-Ha-ras, c-Ki-ras, c-myc, c-myb, p53, c-fes, c-abl, c-kit, or Pim-1 or of growth factor genes such as IL3, G-CSF, M-CSF, GM-CSF, or Epo (data not shown). We have shown in this study that the three Fim regions are located on different mouse chromosomes. This eliminates the possibility that Fim-i and Fim-3 represent different parts of the same locus.
By examining restriction enzyme polymorphism between M. spretus and BALB/c or C57BL/6 mice, we were able to map Fim-i and Fim-3 to mouse chromosomes 13 and 3, respectively. Fim-i was located at 14.5 ± 5.0 cM of the variable region of the -y chain of the T-cell receptor gene and at the same distance from the PL5 marker. An insertion locus of the hepatitis B genome in transgenic mice (4/12 sequences) has recently been mapped to mouse chromosome 13 (15) . This insertional locus is at 2.0 ± 2.0 cM of the PL5 marker and is genetically linked to the Fim-i integration region. Interestingly, no oncogene, growth factor gene, or MuLV integration site has yet been assigned to chromosome
13.
Data from interspecific backcross analysis placed Fim-3 on chromosome 3 but at some distance from all the markers used. A new integration site of ecotropic MuLV in spontaneous myeloid tumors of AKXD mice, called Evi-J, has recently been mapped on the proximal part of chromosome 3 (26, 27) . Our genetic analysis showed that Fim-3 and Evi-J were separated by less than 2 cM, since no recombinant between the two loci was detected among 90 animals tested. The published maps of Evi-l and Fim-3 are different, and therefore they do not represent identical regions of the same locus. Proviruses inserted in the Fim-3 region are not clustered but rather scattered over at least 17 kb. In fact, the extreme limits of the Fim-3 integration region have not been determined. In contrast, proviral integration in the Evi-i region is limited to less than 0.6 kb (27) . Furthermore, we analyzed 42 F-MuLV-induced myeloid leukemias, previously tested for Fim-3 rearrangements, with the Evi-i pUC1.OHP probe. Three tumors were rearranged with the Evi-i probe (data not shown). None of these three tumors had proviruses inserted into the Fim-3 region. Therefore the mouse chromosomal domains hybridizing with Fim-3 and Evi-i probes do not overlap. Fim-3 and Evi-i could be different regions of the same locus or could represent different genetic loci both involved in myeloid leukemogenesis. At least four different regions of MuLV integration involved in lymphoid leukemogenesis have been mapped on mouse chromosome 15: Mlvi-i, Mlvi-2, Mis-ilPvt-i, and c-myc. Mlvi-l and Mlvi-2, which are localized on the same mouse chromosome, are located on different rat chromosomes and therefore correspond to different genetic loci (43) . Such an approach could help in determining whether or not Fim-3 and Evi-i belong to the same locus. Another approach would be to identify which coding gene is activated by insertion in each locus and to determine whether insertion in the other region results in the activation of the same gene.
A cluster of growth factor and growth factor receptor genes has been found on the long arm of human chromosome 5, including IL3, GM-CSF, PDGF-receptor, c-FMS, and M-CSF genes (34) . IL3 and GM-CSF have been localized on mouse chromosome 11 (1) backcross mice did not reveal cosegregation between c-fis, GM-CSF, and two other chromosome 11 markers, Esterase-3 and MLC1A. No linkage with any other chromosome being found, we localized c-fms by in situ hybridization on the D band of mouse chromosome 18. This confirms the recent localization of c-fms on mouse chromosome 18 by Southern analysis of somatic cell hybrid DNAs (17) . Location of c-fms on mouse chromosome 18 strengthens recent observations on the different organization of the growth factor and receptor genes in humans and mice. Indeed, the M-CSF which is located on human chromosome 5 is not found on mouse chromosome 11 (4) , while G-CSF, which is on human chromosome 17q21 (18) , is on mouse chromosome 11 (4 Cancer.
